Gene Therapy for Duchenne Muscular Dystrophy: Engineering microdystrophin expressing cassettes from recombinant adeno-associated virus for improved clinical efficacy

Nertiyan Elangkovan

Gene Therapy for Duchenne Muscular Dystrophy: Engineering microdystrophin expressing cassettes from recombinant adeno-associated virus for improved clinical efficacy

Nertiyan Elangkovan

Department of Biological Sciences

Research output: Thesis › Doctoral Thesis

66 Downloads (Pure)

Original language	English
Qualification	Ph.D.
Awarding Institution	Royal Holloway, University of London
Supervisors/Advisors	Popplewell, Linda, Supervisor Dickson, George, Supervisor
Award date	1 Oct 2021
Publication status	Unpublished - 2021

Keywords

AAV vector
Gene Therapy
Duchenne muscular dystrophy
microdystrophin

Access to Document

2021ElangkovanNPhD

Cite this

@phdthesis{c5724a9a767847889794e2383c9452aa,

title = "Gene Therapy for Duchenne Muscular Dystrophy: Engineering microdystrophin expressing cassettes from recombinant adeno-associated virus for improved clinical efficacy",

keywords = "AAV vector, Gene Therapy, Duchenne muscular dystrophy, microdystrophin",

author = "Nertiyan Elangkovan",

year = "2021",

language = "English",

school = "Royal Holloway, University of London",

}